MYC and neoplasm: MYC gene mutations have been associated with promoting tumor immune evasion through multiple mechanisms, including suppression of interferon signaling, downregulation of antigen presentation (such as MHC class I), upregulation of immune checkpoint molecules, and remodeling of the tumor microenvironment.